Research graph
References from Adherence in initiators of combination therapy among drug-naïve patients with type 2 diabetes: A real-world study using group-based trajectory model. Local targets link to admitted publications; unresolved targets remain external evidence.
Iron metabolism markers and lower extremity arterial disease in people with type 2 diabetes
10.2147/dmso.s380803 · 2022 · External reference
Determinants of poor treatment adherence among patients with type 2 diabetes and limited health literacy: a scoping review
2022 · External reference
Self-reported adherence to medication among patients with type II diabetes mellitus attending a tertiary care hospital of Delhi
2019 · External reference
Adherence to oral antidiabetic drugs in patients with type 2 diabetes: systematic review and meta-analysis
10.3390/jcm12051981 · 2023 · External reference
Medication adherence among type 2 diabetes mellitus patients: a cross sectional study in Rural Karnataka (India)
10.30958/ajhms.8-2-2 · 2021 · External reference
Economic costs of diabetes in the U.S. in 2022
10.2337/dci23-0085 · 2024 · External reference
Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999–2018
10.1001/jama.2021.9883 · 2021 · External reference
Comparison of medication adherence and persistence in type 2 diabetes: a systematic review and meta-analysis
10.1111/dom.13160 · 2018 · External reference
Microvascular and macrovascular complications of type 2 diabetes mellitus: exome wide association analyses
10.3389/fendo.2023.1143067 · 2023 · External reference
Adherence to a healthy lifestyle in association with microvascular complications among adults with type 2 diabetes
10.1001/jamanetworkopen.2022.52239 · 2023 · External reference
9. Pharmacologic approaches to glycemic treatment: standards of care in Diabetes-2023
10.2337/dc23-s009 · 2023 · External reference
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
10.1016/s2213-8587(19)30184-6 · 2019 · External reference
Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis
10.1111/dom.12233 · 2014 · External reference
Multidrug treatment of type 2 diabetes: a challenge for compliance
10.2337/dc11-s235 · 2011 · External reference
Polypharmacy and medication adherence in patients with type 2 diabetes
10.2337/diacare.26.5.1408 · 2003 · External reference
Assessing the performance of group-based trajectory modeling method to discover different patterns of medication adherence
10.1002/pst.2365 · 2024 · External reference
Medication adherence trajectories: a systematic literature review
2020 · External reference
Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence
10.1097/mlr.0b013e3182984c1f · 2013 · External reference
Unresolved reference
2016 · External reference
Trajectories of diabetes medication adherence and hospitalization risk: A retrospective cohort study in a large state Medicaid program
10.1007/s11606-016-3747-6 · 2016 · External reference
Adherence patterns 1 year after initiation of SGLT2 inhibitors: results of a national cohort study
10.37765/ajmc.2024.89591 · 2024 · External reference
Real-world treatment patterns in drug naïve type 2 diabetes population: initial combination therapy vs. sequential step-therapy
10.1016/j.japh.2024.102295 · 2025 · External reference
A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs. loose-dose combination of oral anti-diabetes drugs
10.3111/13696998.2015.1109518 · 2016 · External reference
Hemoglobin A1c outcomes and health care resource use in type 2 diabetes mellitus patients treated with combination oral antidiabetic drugs through step therapy and loose-dose and fixed-dose combinations
2012 · External reference
Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus
10.1185/03007995.2010.536755 · 2011 · External reference
STROBE reporting guidelines for observational studies
10.1001/jamasurg.2021.0528 · 2021 · External reference
Methods for measuring multiple medication adherence: a systematic review–report of the ISPOR medication adherence and persistence special interest group
10.1016/j.jval.2018.08.006 · 2019 · External reference
Unresolved reference
External reference
Regimen simplification and medication adherence: fixed-dose versus loose-dose combination therapy for type 2 diabetes
10.1371/journal.pone.0250993 · 2021 · External reference
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
10.1097/01.mlr.0000182534.19832.83 · 2005 · External reference
A SAS procedure based on mixture models for estimating developmental trajectories
10.1177/0049124101029003005 · 2001 · External reference
Unresolved reference
2005 · External reference
Group-based multi-trajectory modeling
10.1177/0962280216673085 · 2018 · External reference
Introducing the fit-criteria assessment plot – a visualisation tool to assist class enumeration in group-based trajectory modelling
10.1177/0962280215598665 · 2017 · External reference
Group-based trajectory modeling: an overview
2010 · External reference
Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review
10.3389/fendo.2023.1301093 · 2023 · External reference
